Industrial biomanufacturing utilizes biological systems (e.g., living microorganisms, resting cells, animal cells, plant cells, tissues, enzymes, or in vitro synthetic (enzymatic) systems) to produce commercial biomolecules for use in the agricultural, food, materials, energy, and pharmaceutical industries. Products are isolated from natural sources, such as blood, cultures of microbes, animal cells, or plant cells grown in specialized equipment or dedicated cultivation environments. The cells/tissues or enzymes used may be natural or modified by genetic engineering, metabolic engineering, synthetic biology, and protein engineering.
It is rapidly emerging as a transformative force in the global manufacturing landscape, promising sustainable solutions to meet the world's growing demand for materials, chemicals, and energy. As we enter a new era of biotechnology and sustainable manufacturing, industrial biomanufacturing stands at the forefront of innovation. By harnessing the power of living organisms, particularly microorganisms and cell cultures, this field offers a path to produce a wide range of products with greater efficiency, reduced environmental impact, and enhanced performance characteristics.
This comprehensive market report provides an in-depth analysis of the rapidly growing industrial biomanufacturing sector, covering key technologies, market trends, and growth projections from 2025 to 2035. As industries worldwide shift towards more sustainable and bio-based production methods, industrial biomanufacturing is poised to play a pivotal role in the future of manufacturing across multiple sectors.
Report contents include:
- Detailed market size estimates and growth forecasts for the global industrial biomanufacturing market from 2025 to 2035
- Analysis of key application sectors including:
- Biopharmaceuticals: Including monoclonal antibodies, recombinant proteins, vaccines, cell and gene therapies, and more. Emerging technologies like synthetic biology and cell-free systems revolutionizing biopharmaceutical production.
- Industrial Enzymes: Analysis of enzymes used in detergents, food processing, biofuels, textiles, and other industries. The report examines how engineered enzymes are enabling new industrial applications.
- Biofuels: In-depth look at bioethanol, biodiesel, biogas, and advanced biofuels. The report analyzes feedstocks, conversion technologies, and emerging trends like algae-based biofuels.
- Bioplastics: Coverage of bio-based and biodegradable plastics like PLA, PHA, bio-PE, and others. The report examines how bioplastics are transforming packaging, automotive, and other industries.
- Biochemicals: Analysis of bio-based organic acids, alcohols, polymers, and other platform chemicals. The report looks at how biochemicals are replacing petrochemicals in various applications.
- Bio-Agritech: Examination of biopesticides, biofertilizers, and other biological crop inputs. The report covers emerging technologies like RNA interference for crop protection.
- Comprehensive overview of biomanufacturing technologies, processes, and production methods
- Profiles of over 1,100 companies active in the industrial biomanufacturing space. Companies profiled include Aanika Biosciences, Allozymes, Amyris, Aralez Bio, BBGI, Biomatter, Biovectra, Bucha Bio, Byogy Renewables, Cascade Biocatalysts, Constructive Bio, Cryotech, Debut Biotechnology, Enginzyme AB, Enzymit, eversyn, Erebagen, Eligo Bioscience, Evolutor, EV Biotech, FabricNano, Ginkgo Bioworks, Hyfe, Invizyne Technologies, LanzaTech, Lygos, Mammoth Biosciences, Novozymes A/S, NTx, Origin Materials, Pow.bio, Protein Evolution, Samsara Eco, Solugen, Synthego, Taiwan Bio-Manufacturing Corp. (TBMC), Twist Bioscience, Uluu, Van Heron Labs, Verde Bioresins, and Zya.
- Assessment of market drivers, challenges, and opportunities shaping the industry.
- Assessment of technology landscape-key biomanufacturing technologies and processes, including:
- Fermentation and cell culture systems
- Metabolic engineering and synthetic biology
- Downstream processing and purification methods
- Analytical techniques and quality control
- Scale-up strategies and continuous manufacturing
- Emerging technologies like cell-free systems and microfluidics
- The evolving regulatory environment for industrial biomanufacturing, including:
- Regulations governing genetically modified organisms (GMOs)
- Biofuel blending mandates and incentives
- Approval pathways for biopharmaceuticals and biosimilars
- Standards and certifications for bio-based products
- Analysis of investment trends in industrial biomanufacturing, including:
- Venture capital funding for synthetic biology startups
- Public and private investments in bioprocessing infrastructure
- M&A activity and strategic partnerships
- Government funding and incentives for bio-based industries
- Assessment of future prospects for industrial biomanufacturing, examining:
- Emerging application areas and end-user industries
- Technological innovations on the horizon
- Potential disruptive technologies and business models
- Long-term growth projections to 2035
Who Should Read This Report:
- Biomanufacturing companies and synthetic biology firms
- Pharmaceutical and biotechnology companies
- Chemical and materials manufacturers
- Biofuel producers and energy companies
- Food and beverage manufacturers
- Agricultural input suppliers
- Equipment and technology providers
- Investors and financial analysts
- Government agencies and policymakers
- Research institutions and academics